169 related articles for article (PubMed ID: 8556519)
1. Antibody-dependent enhancement of respiratory syncytial virus infection by sera from young infants.
Osiowy C; Horne D; Anderson R
Clin Diagn Lab Immunol; 1994 Nov; 1(6):670-7. PubMed ID: 8556519
[TBL] [Abstract][Full Text] [Related]
2.
van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O
J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of the neutralizing antibody response to respiratory syncytial virus infections in a birth cohort.
Sande CJ; Mutunga MN; Okiro EA; Medley GF; Cane PA; Nokes DJ
J Med Virol; 2013 Nov; 85(11):2020-5. PubMed ID: 23983183
[TBL] [Abstract][Full Text] [Related]
4. Age-Specific Profiles of Antibody Responses against Respiratory Syncytial Virus Infection.
Jounai N; Yoshioka M; Tozuka M; Inoue K; Oka T; Miyaji K; Ishida K; Kawai N; Ikematsu H; Kawakami C; Shimizu H; Mori M; Ishii KJ; Takeshita F
EBioMedicine; 2017 Feb; 16():124-135. PubMed ID: 28111238
[TBL] [Abstract][Full Text] [Related]
5. Role of complement in neutralization of respiratory syncytial virus.
Yoder SM; Zhu Y; Ikizler MR; Wright PF
J Med Virol; 2004 Apr; 72(4):688-94. PubMed ID: 14981775
[TBL] [Abstract][Full Text] [Related]
6. Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus.
Shinoff JJ; O'Brien KL; Thumar B; Shaw JB; Reid R; Hua W; Santosham M; Karron RA
J Infect Dis; 2008 Oct; 198(7):1007-15. PubMed ID: 18702606
[TBL] [Abstract][Full Text] [Related]
7. Neutralizing and enhancing activities of human respiratory syncytial virus-specific antibodies.
Gimenez HB; Chisholm S; Dornan J; Cash P
Clin Diagn Lab Immunol; 1996 May; 3(3):280-6. PubMed ID: 8705669
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV.
Widjaja I; Wicht O; Luytjes W; Leenhouts K; Rottier PJM; van Kuppeveld FJM; Haijema BJ; de Haan CAM
J Virol; 2016 Jul; 90(13):5965-5977. PubMed ID: 27099320
[TBL] [Abstract][Full Text] [Related]
9. Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease.
van Erp EA; Luytjes W; Ferwerda G; van Kasteren PB
Front Immunol; 2019; 10():548. PubMed ID: 30967872
[TBL] [Abstract][Full Text] [Related]
10. Group- and genotype-specific neutralizing antibody responses against respiratory syncytial virus in infants and young children with severe pneumonia.
Sande CJ; Mutunga MN; Medley GF; Cane PA; Nokes DJ
J Infect Dis; 2013 Feb; 207(3):489-92. PubMed ID: 23175761
[TBL] [Abstract][Full Text] [Related]
11. Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies.
Piedra PA; Jewell AM; Cron SG; Atmar RL; Glezen WP
Vaccine; 2003 Jul; 21(24):3479-82. PubMed ID: 12850364
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the antibody specificities of human convalescent-phase sera against the attachment (G) protein of human respiratory syncytial virus: influence of strain variation and carbohydrate side chains.
Palomo C; Cane PA; Melero JA
J Med Virol; 2000 Apr; 60(4):468-74. PubMed ID: 10686032
[TBL] [Abstract][Full Text] [Related]
13. The immune response of small children by antibodies of different classes to respiratory syncytial virus (RSV) proteins.
Wilczyński J; Lukasik B; Torbicka E; Tranda I; Brzozowska-Binda A
Acta Microbiol Pol; 1994; 43(3-4):369-79. PubMed ID: 7740987
[TBL] [Abstract][Full Text] [Related]
14. Antigenic Fingerprinting of Respiratory Syncytial Virus (RSV)-A-Infected Hematopoietic Cell Transplant Recipients Reveals Importance of Mucosal Anti-RSV G Antibodies in Control of RSV Infection in Humans.
Fuentes S; Hahn M; Chilcote K; Chemaly RF; Shah DP; Ye X; Avadhanula V; Piedra PA; Golding H; Khurana S
J Infect Dis; 2020 Feb; 221(4):636-646. PubMed ID: 31745552
[TBL] [Abstract][Full Text] [Related]
15. Effects of Alterations to the CX3C Motif and Secreted Form of Human Respiratory Syncytial Virus (RSV) G Protein on Immune Responses to a Parainfluenza Virus Vector Expressing the RSV G Protein.
Liang B; Kabatova B; Kabat J; Dorward DW; Liu X; Surman S; Liu X; Moseman AP; Buchholz UJ; Collins PL; Munir S
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651356
[TBL] [Abstract][Full Text] [Related]
16. Virus-Specific Antibody, Viral Load, and Disease Severity in Respiratory Syncytial Virus Infection.
Walsh EE; Wang L; Falsey AR; Qiu X; Corbett A; Holden-Wiltse J; Mariani TJ; Topham DJ; Caserta MT
J Infect Dis; 2018 Jun; 218(2):208-217. PubMed ID: 29546402
[TBL] [Abstract][Full Text] [Related]
17. Antibodies in lymphocyte supernatants can distinguish between neutralising antibodies induced by RSV vaccination and pre-existing antibodies induced by natural infection.
Gerretsen HE; Capone S; Vitelli A; Reyes LS; Thompson A; Jones C; Green CA; Pollard AJ; Sande CJ
Vaccine; 2018 Nov; 36(46):6988-6994. PubMed ID: 30318168
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the respiratory syncytial virus G-directed neutralizing antibody response in the human airway epithelial cell model.
Kishko M; Catalan J; Swanson K; DiNapoli J; Wei CJ; Delagrave S; Chivukula S; Zhang L
Virology; 2020 Nov; 550():21-26. PubMed ID: 32866728
[TBL] [Abstract][Full Text] [Related]
19. Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze.
Stensballe LG; Ravn H; Kristensen K; Agerskov K; Meakins T; Aaby P; Simões EA
J Allergy Clin Immunol; 2009 Feb; 123(2):398-403. PubMed ID: 19101023
[TBL] [Abstract][Full Text] [Related]
20. Undetectable IgE responses after respiratory syncytial virus infection.
Toms GL; Quinn R; Robinson JW
Arch Dis Child; 1996 Feb; 74(2):126-30. PubMed ID: 8660074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
